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ABSTRACT
Huntington’s disease (HD) is a fatal genetic disorder that causes the progressive breakdown of nerve cells 
in the brain. It deteriorates a person’s physical and mental abilities usually during their prime working 
years and there is no cure. HD is known as the quintessential family disease because every child of a parent 
with HD has a 50% chance of inheriting the faulty gene. Symptoms usually appear between the ages of 30 to 
50, and worsen over a 10- to 25-year period. Ultimately, the weakened individual succumbs to pneumonia, 
heart failure or other complications. Everyone has the gene that causes HD, but only those that inherit the 
expansion of the gene will develop HD and perhaps pass it on to each of their children. Every person who 
inherits the expanded HD gene will eventually develop the disease. Over time, HD affects the individual’s 
ability to reason, walk and speak. Hereby, we describe the case of a 35-year-old patient with HD presenting 
with cognitive and motor disturbances to underline the diagnostic challenges and differential diagnostic 
options.
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Huntington’s disease (HD) is an inherited 
genetic disease leading to progressive degeneration 
of nerve cells in certain areas of the brain. The loss 
of nerve cells leads to the manifestation of a number 
of symptoms including uncontrollable movements 
(chorea), cognitive deficit, emotional disturbances, 
and a variety of psychiatric symptoms. The onset 
of symptoms is often in middle age, but the time of 
manifestation may differ. The mutant protein in HD 
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found on ophthalmological examination. Neuropsy-
chological assessment showed mild memory impair-
ment, decreased verbal fluency and active attention. 
MMSE score was 27. Anxiety was noted. Finally, ge-
netic analysis was performed. Expanded CAG trip-
let-repeat on the HTT gene was found, confirming 
the diagnosis of HD.
On admission of the patient to the Clinic, sev-
eral possible differential diagnoses were discussed, 
including CNS infections, multiple sclerosis, Fried-
reich’s disease, and HD. Later, when additional fam-
ily history data were obtained, attention was focused 
on HD. Multiple system atrophy was suggested by 
MRI, but was disregarded because of no match with 
the history and clinical data. The diagnosis of HD 
was confirmed on the basis of clinical symptoms, 
coinciding with family history and genetic analysis. 
PET imaging was also in line with this diagnosis.
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is named huntingtin and results from an expanded 
CAG repeat (1). It causes neuronal dysfunction 
and death through disruption of proteostasis, 
transcription and mitochondrial function and direct 
toxicity (2). Genetic testing confirms the diagnosis, but 
mutation gene carriers usually remain asymptomatic 
for years. Before the clinical manifestations become 
apparent, alterations in the basal ganglia and cortex 
are present and can be detected using techniques, 
such as PET imaging (3). Sometimes the diagnosis 
can be challenging even in the clinical stage.
A 35-year-old female patient was admitted in 
the First Clinic of Neurology of St. Marina University 
Hospital in Varna, Bulgaria, with complaints of fre-
quent forgetfulness and swaying, mostly to the right, 
for the last 5 years, with gradual progression. She 
reported that for about 2 years she had had “trem-
bling” of the fingers and toes, and her speech had de-
teriorated. One year before admission to the hospi-
tal, swallowing of solid foods had become difficult, 
the patient was choking at times, and was experienc-
ing episodes of urinary incontinence. The patient re-
ported no accompanying diseases. Family history in-
cluded mother with schizophrenia who had died of 
stroke, uncle who had died at the age of 33 years with 
memory, speech and motor disturbances, and grand-
father who had died at the age of 40 years with simi-
lar symptoms. Both uncle and grandfather are on the 
mother’s side. Unfortunately, no medical documents 
were available.
The neurological examination showed dysar-
thria and dysphonia, quadripyramidal syndrome 
with pronounced spastic paraparesis, bilateral dys-
metria with mild intention tremor, negative Rom-
berg test, paretic-ataxic gait, paraesthesiae for the 
palms and soles, urinary incontinence, and brad-
ypsychia. The hematology and chemistry indicators 
were normal. Serology testing showed positive Anti-
Borrelia burgdorferi IgM. Brain MRI (Fig. 1) gave ev-
idence of atrophic changes in the cerebellum, pons, 
parietal and occipital lobes. Cerebellar type multiple 
system atrophy and spinocerebellar ataxia were sug-
gested as possible differential diagnoses. PET/CT of 
the brain (Fig. 2) demonstrated severe hypometabo-
lism in both striatums, relatively reduced activity in 
the pons and suspected reduction of activity in the 
cerebellum. Echocardiography and indirect laryn-
goscopy were normal. No Kaiser-Fleischer ring was 
Fig. 1. MRI of the brain, axial and coronal planes
Fig. 2. PET/CT of the brain
